Solid-organ transplantation evaluation

CSA use in patients with healthy native kidneys is clearly associated with the potential of renal injury, which ultimately may lead to severe chronic kidney disease (CKD), dialysis or renal transplantation [271, 280, 424, 553, 554]. In fact, recent data indicate an 11-fold increase in the referral for renal transplant evaluation among non-solid organ transplant recipients [555]. 

Chandrakantan A, de Mattos AM, Naftel D, Crosswy A, KIrklln J, Curtis JJ. Increasing referral for renal transplant evaluation In recipients of nonrenal solid-organ transplants a single-center experience. Clin J Am Soc Nephrol. 2006 1 832-836.450. 

Partovi, N. Chan, W. Nimmo, C.R. Evaluation of a patient education program for solid organ transplant patients. Can. J. Hosp. Pharm. 1995, 48 (2), 72-78. 

Observational studies Adverse reactions to anidulafungin in solid organ transplantation recipients have been evaluated in a retrospective analysis of 86 consecutive patients [65 ]. Recipients from 14 centres were included who received anidulafungin for atleast 48 h for the treatment of invasive fungal infections or as prophylaxis. 

Bonatti H, Barroso 2nd LF, Sawyer RG, Kotton CN, Sifri CD. Ctyptosporidittm enteritis in solid organ transplant recipients multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations. Transpl Infect Dis December 2012 14(6) 635 8. PubMed PMID 22340660. Epub 2012/02/22. eng. 

---